You searched for "wellbeing"

1753 results found

The Worshipful Company of Spectacle Makers awards two Master’s Medals for early career research

The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of two Master’s Medals for 2025. Fabian Yii from Edinburgh was awarded the Master’s Medal for his paper, 'Fundus Refraction Offset as a Personalized Biomarker for 12-Year Risk...

OSA chair passes to a delighted James Conway

Longstanding OSA Director James Conway is delighted to have been appointed as the new OSA Chair, following the retirement of Roy Stoner after a three-year tenure. The OSA’s AGM and Christmas lunch at the Bloomsbury Hotel, London, saw Roy pass...

College comments on the DHSC’s update on GOS sight test fees for England and clinical placement training payments for 2025/2026

This week, the Department of Health and Social Care published details of its confirmed NHS sight test fee and NHS domiciliary fees from 1 April 2025, continuing professional development payments for 2024, and clinical placement training payments from 1 April...

Conference Report: Retina UK 2025

The Retina UK Annual Conference 2025 took place at the Holiday Inn London in London, UK, on 20 September and was hosted both in-person and online. The event included expert speakers, healthcare professionals, and patients with lived experience with retinal...

Sheraz Daya awarded prestigious IIRSI gold medal for contribution to ophthalmology

Centre for Sight, the UK’s leading and most trusted centre of excellence for advanced eye care, innovation and life-changing results, is proud to announce that its Founder and Medical Director, Sheraz Daya, has been awarded the prestigious IIRSI Gold Medal...

Prognosis of ocular motor cranial nerve palsies caused by pituitary adenoma and meningioma

The authors present a retrospective cohort study with the aim of comparing recovery rate and time of ocular motor cranial nerve palsies (CNP) caused by pituitary adenoma or meningioma. Cases were identified from a single tertiary referral centre over a...

Comparison of the efficacy of anti-VEGFs agents in nvAMD

This retrospective multicentric study conducted in Israel and Canada, compared the efficacy of bevacizumab, aflibercept 2mg and ranibizumab as first-line treatments for neovascular age-related macular degeneration (nvAMD). Included were treatment-naïve nvAMD eyes receiving ≥12 months of treat-and-extend (T&E) anti-VEGF therapy...

Glaucoma UK appoints Professor Cecilia Fenerty as new Chair of Trustees

Glaucoma UK has appointed Professor Cecilia Fenerty as its new Chair of Trustees following the charity’s Annual General Meeting in March 2026. Professor Fenerty succeeds Professor Anthony King, who stepped down after completing four years as Chair and nine years...

Early vitrectomy for endophthalmitis offers hope to patients

A Phase 2 feasibility study published today in the prestigious Nature Communications Medicine journal has shown that early vitrectomy surgery treatment for acute endophthalmitis can be potentially more beneficial to patients’ vision compared with the current antibiotic-first approach. This is...

RANZCO Congress 2025

The Royal Australian and New Zealand College of Ophthalmologists Annual Congress 2025

UK Paediatric Glaucoma Society Annual Meeting 2025

by Hussain Aluzri, Junior Glaucoma Cinical Research Fellow, Birmingham Midland Eye Centre, UK. The UKPGS 2025 conference was another resounding success, held on 24 January 2025 at the Cavendish Conference Centre, London. The event commenced with an opening address by...

Cambridge Ophthalmological Symposium 2024: Evolution and the Eye

by Anushka Irodi, Y5 Medical Student, University of Cambridge, UK. The 52nd Cambridge Ophthalmological Symposium, a renowned two-day national meeting, took place on September 5th and 6th, 2024 at St John’s College, Cambridge, UK. It brought together international leading minds...